-
Mashup Score: 0Do Liver Conditions Up Risk of Severe COVID-19? It Depends - 3 year(s) ago
No higher risk of death in liver transplant, but more severe disease in patients with cirrhosis, NAFLD
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Surveillance Models Score Liver Ca Risk After HCV Cure - 3 year(s) ago
Studies refute idea HCV cure is equal to elimination of HCC risk, expert says
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Currently, there is convincing evidence that earlier stage detection of #hepatocellular carcinoma through surveillance is more amenable to curative therapies and improved overall survival." @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/miC3zzQ4Hf
-
-
Mashup Score: 2Liver Fibrosis Assessment Advocated for Routine T2D Care - 3 year(s) ago
Pilot study ID’d ‘significant’ number of patients with advanced liver disease despite normalenzymes
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "That is almost a seven-fold increase in the detection of advanced #liver disease compared to standard of care." @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/z2TumzcHqO
-
-
Mashup Score: 2
Significant reductions versus liraglutide, placebo, but GI effects questioned
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "A combination of glucagon and GLP-1 causes more accentuated reduction of GI emptying in the first few weeks." #NAFLD @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/RU8EvjxFBd
-
-
Mashup Score: 0Cirrhosis Patients OK for Fecal Transplant - 3 year(s) ago
Safe and possibly effective for alcohol cravings
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "The #gut is one of the largest producers of rich neurotransmitters, such as dopamine, serotonin, short-chain fatty acids, and all of these can affect the brain, which could be a mechanism of action.” #Cirrhosis @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/iSvh6XAClC
-
-
Mashup Score: 0Early Studies Make Headway in Chronic HBV Tx - 3 year(s) ago
Investigational agents prove safe, tolerable
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Common treatment-emergent adverse events [TEAE] were generally #gastrointestinal-related, and most cases were mild and transient." @AmerGastroAssn #HBV #ILC2020 #AGAConfRep https://t.co/7CLA8vZQF3
-
-
Mashup Score: 0Combo Tx Upped Transplant-Free Survival in Japanese PBC Patients - 4 year(s) ago
Adding bezafibrate to UDCA showed promise in large retrospective analysis
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Japanese clinicians and researchers were the first to combine UDCA with #bezafibrate treatment in patients who did not respond adequately to #UDCA alone." @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/ee5aKSRmpY
-
-
Mashup Score: 0
New data showing efficacy and tolerability with ADP-A2AFP, alpha-fetoprotein–directed specific peptide enhanced affinity receptor T-cells, suggest that further research evaluating the 5 billion or more cell dosing regimen is warranted in hepatocellular carcinoma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Bruno Sangro, MD, PhD, of @ClinicaNavarra, discusses the evolution of the HCC paradigm. @EASLnews #ILC2020 #hpbcsm https://t.co/14qIgy8IIl https://t.co/pCP4jbl0Dv
-
-
Mashup Score: 0
New data showing efficacy and tolerability with ADP-A2AFP, alpha-fetoprotein–directed specific peptide enhanced affinity receptor T-cells, suggest that further research evaluating the 5 billion or more cell dosing regimen is warranted in hepatocellular carcinoma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During #ILC2020, findings from a first-in-human phase 1 trial evaluating ADP-A2AFP were presented in patients with HCC who are not amenable to transplant, resection, or locoregional treatment. @EASLnews @ClinicaNavarra #hpbcsm https://t.co/FNCenr4b4W
-
-
Mashup Score: 0First-in-Human T-Cell Therapy Warrants Further Investigation With Acceptable Tolerability and Efficacy Signals - 4 year(s) ago
New data showing efficacy and tolerability with ADP-A2AFP, alpha-fetoprotein–directed specific peptide enhanced affinity receptor T-cells, suggest that further research evaluating the 5 billion or more cell dosing regimen is warranted in hepatocellular carcinoma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
First-in-Human T-Cell Therapy Warrants Further Investigation With Acceptable Tolerability and Efficacy Signals @ClinicaNavarra @EASLnews #ILC2020 #hpbcsm https://t.co/4qJTfOj3Jr
-
ICYMI: "This is very important data, because there was a lot of concern with transplant patients that there may be a higher risk of dying." @AmerGastroAssn #ILC2020 #AGAConfRep https://t.co/7vqG4GELJC https://t.co/Zvb8IodOLj